Cargando…

O7.6. META-ANALYSIS OF EFFICACY OF COGNITIVE ENHANCERS FOR PATIENTS WITH SCHIZOPHRENIA-SPECTRUM DISORDERS

BACKGROUND: Cognitive impairment is a core feature of schizophrenia, which is predictive for functional outcomes and should therefore be one of the main treatment targets. Pharmacological enhancement of cognition has been a main field of research in the last decades, investigating almost all neurotr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sinkeviciute, Igne, Begemann, Marieke, Prikken, Merel, Oranje, Bob, Johnsen, Erik, Lei, Wan U, Hugdahl, Kenneth, Kroken, Rune A, Rau, Carina, Jacobs, Jolien, Mattaroccia, Silvia, Sommer, Iris E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888009/ http://dx.doi.org/10.1093/schbul/sby015.235

Ejemplares similares

Efficacy of different types of cognitive enhancers for patients with schizophrenia: a meta-analysis
por: Sinkeviciute, Igne, et al.
Publicado: (2018)

The effect of raloxifene augmentation in men and women with a schizophrenia spectrum disorder: a systematic review and meta-analysis
por: de Boer, Janna, et al.
Publicado: (2018)

Priapism in Antipsychotic Drug Use: A Rare but Important Side Effect
por: Sinkeviciute, Igne, et al.
Publicado: (2012)

Hallucinations in acutely admitted patients with psychosis, and effectiveness of risperidone, olanzapine, quetiapine, and ziprasidone: a pragmatic, randomized study
por: Johnsen, Erik, et al.
Publicado: (2013)

Negative valence of hallucinatory voices as predictor of cortical glutamatergic metabolite levels in schizophrenia patients
por: Hjelmervik, Helene, et al.
Publicado: (2021)

Sex differences in antipsychotic efficacy and side effects in schizophrenia spectrum disorder: results from the BeSt InTro study
por: Hoekstra, Sanne, et al.
Publicado: (2021)

White Matter Microstructural Differences between Hallucinating and Non-Hallucinating Schizophrenia Spectrum Patients
por: Beresniewicz, Justyna, et al.
Publicado: (2021)

Differential Effectiveness of Atypical Antipsychotics on Hallucinations: A Pragmatic Randomized Controlled Trial
por: Sinkeviciute, Igne, et al.
Publicado: (2021)

Antidepressive Effectiveness of Amisulpride, Aripiprazole, and Olanzapine in Patients With Schizophrenia Spectrum Disorders: A Secondary Outcome Analysis of a Pragmatic, Randomized Trial (BeSt InTro)
por: Kjelby, Eirik, et al.
Publicado: (2023)

T73. COGNITIVE CLUSTERING IN SCHIZOPHRENIA SPECTRUM DISORDER AND THE ASSOCIATION WITH BRAIN VOLUME
por: Oomen, Priscilla, et al.
Publicado: (2020)

The Beliefs about Voices Questionnaire – Revised: A factor structure from 450 participants
por: Strauss, Clara, et al.
Publicado: (2018)

Intra-Regional Glu-GABA vs Inter-Regional Glu-Glu Imbalance: A 1H-MRS Study of the Neurochemistry of Auditory Verbal Hallucinations in Schizophrenia
por: Hjelmervik, Helene, et al.
Publicado: (2020)

Constructing the Immune Signature of Schizophrenia for Clinical Use and Research; An Integrative Review Translating Descriptives Into Diagnostics
por: Kroken, Rune A., et al.
Publicado: (2019)

T16. SCHIZOPHRENIA SPECTRUM DISORDER: DEPRESSION TRAJECTORIES AND IMMUNE MARKERS
por: Hoprekstad, Gunnhild, et al.
Publicado: (2020)

Dynamic Functional Connectivity Patterns in Schizophrenia and the Relationship With Hallucinations
por: Weber, Sarah, et al.
Publicado: (2020)

F184. TESTING THE GABA-GLUTAMATE HYPOTHESIS FOR SCHIZOPHRENIA IN RELATION TO AUDITORY HALLUCINATIONS - PRELIMINARY RESULTS
por: Hjelmervik, Helene, et al.
Publicado: (2018)

An fMRI Study of Neuronal Activation in Schizophrenia Patients with and without Previous Cannabis Use
por: Løberg, Else-Marie, et al.
Publicado: (2012)

T134. THE ROLE OF THE DEFAULT MODE NETWORK IN SCHIZOPHRENIA AND AUDITORY VERBAL HALLUCINATIONS – AN INVESTIGATION OF DYNAMIC FMRI RESTING STATE CONNECTIVITY
por: Weber, Sarah, et al.
Publicado: (2020)

Corrigendum: An fMRI Study of Neuronal Activation in Schizophrenia Patients with and without Previous Cannabis Use
por: Løberg, Else-Marie, et al.
Publicado: (2013)

Impact of glutamate levels on neuronal response and cognitive abilities in schizophrenia
por: Falkenberg, Liv E., et al.
Publicado: (2014)

F108. PSYCHOTIC EXPERIENCES IN A NORWEGIAN SAMPLE - TENTATIVE RESULTS OF A QUESTIONNAIRE VALIDATION
por: Kusztrits, Isabella, et al.
Publicado: (2018)

S3. CHILDHOOD TRAUMA AND COGNITIVE FUNCTIONING IN SCHIZOPHRENIA SPECTRUM DISORDERS: EFFECT OF FREQUENCY AND TYPE OF CHILDHOOD TRAUMA
por: Morkved, Nina, et al.
Publicado: (2018)

Patients with Schizophrenia Fail to Up-Regulate Task-Positive and Down-Regulate Task-Negative Brain Networks: An fMRI Study Using an ICA Analysis Approach
por: Nygård, Merethe, et al.
Publicado: (2012)

Corrigendum: Patients with schizophrenia fail to up-regulate task-positive and down-regulate task-negative brain networks: an fMRI study using an ICA analysis approach
por: Nygård, Merethe, et al.
Publicado: (2013)

Trajectories of response in schizophrenia-spectrum disorders: A one-year prospective cohort study of antipsychotic effectiveness
por: Drosos, Petros, et al.
Publicado: (2022)

M41. TRAJECTORIES AND PREDICTORS OF OUTCOME IN SCHIZOPHRENIA: THE BENEFICIAL ROLE OF AMISULPRIDE
por: Drosos, Petros, et al.
Publicado: (2020)

Neural Activation in the Ventromedial Prefrontal Cortex Precedes Conscious Experience of Being in or out of a Transient Hallucinatory State
por: Hugdahl, Kenneth, et al.
Publicado: (2022)

Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study
por: Kroken, Rune A, et al.
Publicado: (2009)

A Critical Review of Pro-Cognitive Drug Targets in Psychosis: Convergence on Myelination and Inflammation
por: Kroken, Rune A., et al.
Publicado: (2014)

Does childhood trauma influence cognitive functioning in schizophrenia? The association of childhood trauma and cognition in schizophrenia spectrum disorders.
por: Mørkved, N., et al.
Publicado: (2020)

F236. CLONIDINE NORMALIZES MMN IN SCHIZOPHRENIA PATIENTS ON STABLE MEDICATION
por: Kruiper, Caitlyn, et al.
Publicado: (2018)

M146. NEUROCHEMICAL MODULATION OF AUDITORY CORTEX FUNCTIONAL CONNECTIVITY IN PATIENTS WITH AUDITORY VERBAL HALLUCINATIONS
por: Weber, Sarah, et al.
Publicado: (2020)

The Association Between Emotion Recognition, Affective Empathy, and Structural Connectivity in Schizophrenia Patients
por: Koevoets, Martijn G. J. C., et al.
Publicado: (2022)

Glutamate- and GABA-Modulated Connectivity in Auditory Hallucinations—A Combined Resting State fMRI and MR Spectroscopy Study
por: Weber, Sarah, et al.
Publicado: (2021)

Use of Benzodiazepines and Antipsychotic Drugs Are Inversely Associated With Acute Readmission Risk in Schizophrenia
por: Strømme, Maria F., et al.
Publicado: (2022)

Pilot-RCT Finds No Evidence for Modulation of Neuronal Networks of Auditory Hallucinations by Transcranial Direct Current Stimulation
por: Marquardt, Lynn, et al.
Publicado: (2022)

T115. PERSONALITY ACROSS THE PSYCHOSIS CONTINUUM: A FINE-GRAINED PERSPECTIVE
por: Begemann, Marieke, et al.
Publicado: (2020)

Cognitive Profile in Ultra High Risk for Psychosis and Schizophrenia: A Comparison Using Coordinated Norms
por: Anda, Liss, et al.
Publicado: (2019)

O2.5. MULTISENSORY INTEGRATION UNDERLYING BODY OWNERSHIP IN SCHIZOPHRENIA AND INDIVIDUALS AT FAMILIAL RISK TO DEVELOP PSYCHOSIS: A STUDY USING THE RUBBER HAND ILLUSION PARADIGM
por: Van Haren, Neeltje, et al.
Publicado: (2018)

Clinical insight among persons with schizophrenia spectrum disorders treated with amisulpride, aripiprazole or olanzapine: a semi-randomised trial
por: Stabell, L.A, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3air7n1plcfvckbn1hs5vu0fg5